The next generation sequencing (NGS) sample preparation market is anticipated to value over USD 2 billion with aCAGR of over 17% during the forecast period 2019-2026.
Next generation sequencing (NGS) is a parallel sequencing method that helps build up a whole human genome rapidly. The technique is used for research, diagnosis, targeted treatment, etc. The NGS sample preparation is an emerging market sector because of its wide range of applications and further research scope. This is the key driver impacting market growth.
On the basis of products, the market is divided into reagents and consumables, library preparation and target enrichment. The library preparation and target enrichment are anticipated to contribute as a major part of the market. This is because both the segments are funded by government and non-government bodies due to its scope in research and biopharmaceuticals. These segments are anticipated to impact market growth.
Based on the applications, the diagnosis of cancer is one of the major drivers which impact the market growth of NGS sample preparation. The rise in the risk and number of cancer patients and the awareness for its preventive measures are increasing the demand for NGS sample preparation market.
Research centres are estimated to have a large share in the market of NGS sample preparation as they get more attention by several funding organizations so that new advancements get promoted. Further projects in the NGS sample preparation are estimated to boost the market growth and influence the CAGR positively.
Inclination towards research in NGS sample preparation and the favorable regulatory authorities are estimated to be the drivers in the growth of the market in North America. The Asia Pacific also has focused on new advancements in NGS sample preparation market due to rising incidence and awareness of genetic disorders.
Key players in the NGS sample preparation market are Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG and so on. Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe.
Competitive Landscape:
• Agilent Technologies has provided NGS assays for the detection of somatic cancer and is expected to be the key factor.
• Agilent Technologies has a target enrichment probe that targets 151 key genes associated with a wide range of cancers.
FutureWise Key Takeaways:
• Drug discovery based on NGS sample preparation
• More focus on target enrichment techniques
Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3351&...
Global Next Generation Sequencing (NGS) Sample Preparation Market Segmentation:
By Product:
• Reagents and consumables market by workflow
• Library preparation and target enrichment market by technology
By Applications:
• Diagnostic applications
• Drug discovery
• Agriculture and animal research
• Other applications
By End User:
• Academic institutes and research centres
• Hospitals and Clinics
• Pharmaceutical and biotechnology companies
• Other end users
By Region:
• North America
• Europe
• Asia Pacific
• Rest of the world
Purchase a Copy & Ask for Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3351&...
Objectives of the Study:
• To provide with an exhaustive analysis on the next generation sequencing (NGS) sample preparation market by products, by applications, by end user and by region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and the rest of the world.
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies.
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 End User-Based Market Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary

4 Premium Insights
4.1 NGS Sample Preparation: Market Overview
4.2 NGS Sample Preparation Market Share, By Product, 2018
4.3 Market, By End User, 2019 vs. 2026 (USD Million)
4.4 Market, By Application, 2019 vs. 2026 (USD Million)
4.5 Market, By Region

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advancements in NGS Platforms
5.2.1.2 Declining Cost of Sequencing
5.2.1.3 Improving Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints
5.2.2.1 End User Budget Constraints in Developing Countries
5.2.3 Opportunities
5.2.3.1 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
5.2.3.2 Increasing Applications of NGS
5.2.4 Challenges
5.2.4.1 Ethical Issues

6 NGS Sample Preparation Market, By Product
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Rising Adoption of NGS is Supporting the Use of NGS Reagents and Consumables
6.3 NGS Workstations
6.3.1 High Throughput and Reduction in Hands-On Time Ensures the Adoption of Workstations in NGS Workflow

7 NGS Reagents and Consumables Market, By Workflow
7.1 Introduction
7.2 Library Preparation
7.2.1 DNA Fragmentation, End Repair, A-Tailing, and Size Selection
7.2.1.1 Availability of Products From Various Players Drives the Market for This Segment
7.2.2 DNA Library Preparation
7.2.2.1 Whole Exome Sequencing
7.2.2.1.1 Wes is More Cost-Effective and Produces Smaller, More Manageable Datasets for Faster Analysis
7.2.2.2 Targeted Sequencing
7.2.2.2.1 Targeted Sequencing Helps to Investigate A Variety of Disease Areas, Such as Oncology, Inherited Diseases, Immunology, and Infectious Diseases
7.2.2.3 Whole Genome Sequencing
7.2.2.3.1 Wgs Enables Clinicians to Understand the Genetic Makeup of Patients and Supports the Diagnosis of Various Diseases
7.2.2.4 Others
7.2.3 RNA Library Preparation
7.2.3.1 Gene Expression Analysis
7.2.3.1.1 Gene Expression Analysis is Adopted on A Large Scale During Immunology & Stem Cell Research and Neurobiology Studies to Evaluate Cell Differentiation and Development
7.2.3.2 Whole Transcriptome Sequencing
7.2.3.2.1 Whole Transcriptome Sequencing Helps in Understanding the Functional Elements of the Genome and Underlying Mechanisms of Development and Disease
7.2.3.3 Other RNA Applications
7.3 Target Enrichment
7.3.1 Targeted Sequencing
7.3.1.1 Increased Adoption of Targeted Sequencing in Several Diagnostics to Drive Market Growth
7.3.2 Whole Exome Sequencing
7.3.2.1 Wes is Increasingly Being Used in Clinical Diagnostics for A Variety of Indications to Identify the Underlying Genetic Cause of Disease
7.3.3 Others
7.4 Quality Control
7.4.1 Importance of Quality Control Step in the NGS Workflow & Rising Number of Research Activities Using NGS Technology are the Key Factors Driving Market Growth

8 NGS Library Preparation & Target Enrichment Market, By Technology 8.1 Introduction
8.2 Sequencing By Synthesis (Sbs)
8.2.1 Sbs has A Wide Customer Base Owing to Its Well-Established Precision in Sequencing as Well as Its Broad Application Base
8.3 Ion Semiconductor Sequencing
8.3.1 Extensive Applications of Ion Semiconductor Sequencing to Drive Market Growth
8.4 Single-Molecule Real-Time Sequencing (Smrt)
8.4.1 High Cost of Smrt-Based Platforms to Restrain Market Growth
8.5 Nanopore Sequencing
8.5.1 Small Size and Low Equipment Costs to Support the Adoption of Nanopore Sequencing Platforms By Various End Users
8.6 Other Sequencing Technologies
9 NGS Sample Preparation Market, By Application
9.1 Introduction
9.2 Diagnostics
9.2.1 Cancer Diagnostics
9.2.1.1 Increasing Cancer Patient Population Across the Globe is Driving This Segment
9.2.2 Infectious Disease Diagnostics
9.2.2.1 Lack of Awareness About NGS-Based Diagnosis for Infectious Diseases is Limiting the Growth of This Market
9.2.3 Reproductive Health Diagnostics
9.2.3.1 Increasing Adoption of Nipt to Drive Market Growth
9.2.4 Other Disease Diagnostic Applications
9.3 Drug Discovery
9.3.1 Increasing Use of NGS During Clinical Trials for Drug Discovery and Development to Drive the Adoption NGS Sample Preparation Products
9.4 Agricultural & Animal Research
9.4.1 Funding & Support for Animal and Plant Genomics Research to Support the Adoption of NGS Sample Preparation Products
9.5 Other Applications

10 NGS Sample Preparation Market, By End User
10.1 Introduction
10.2 Academic Institutes & Research Centers
10.2.1 Availability of Financial Support for Genomics Research to Support the Growth of This Segment
10.3 Hospitals & Clinics
10.3.1 NGS Technology to Witness Significant Adoption in Disease Diagnosis Owing to Its Advantages Over Conventional Methods
10.4 Pharmaceutical & Biotechnology Companies
10.4.1 Continuous Focus of Pharmaceutical and Biotechnology Companies on Targeted therapies for Precision Medicine to Drive the Growth of This
End-User Segment
10.5 Other End Users

11 NGS Sample Preparation Market, By Region
11.1 Introduction
11.2 North America
11.3 US
11.3.1 Favorable Regulatory and Reimbursement Scenario for NGS-Based Diagnostics Tests in the Country Drives the Market
11.4 Canada
11.4.1 Favorable Government Funding Scenario in Canada Boost Genomics Research
11.5 Europe
11.6 Germany
11.6.1 Strong R&D Base in Germany Supports Market Growth
11.7 UK
11.7.1 Use of NGS-Based Test for Disease Diagnosis Will Drive Market Growth
11.8 France
11.8.1 Support for Genomics Research is A Key Driver of Market Growth
11.8.2 RoE
11.9 Asia Pacific
11.9.1 China
11.9.1.1 NGS Players are Focusing on Strengthening their Presence and OfferiNGS in the Country
11.9.2 Japan
11.9.2.1 Growing Genetic Disorder Incidence in Japan is Driving Market Growth
11.9.3 India
11.9.3.1 Awareness on NGS and Its Advantages is Still Growing in India
11.9.4 Rest of Asia Pacific
11.1 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Product Launches
12.3.2 Agreements, Partnerships, and Collaborations
12.3.3 Acquisitions
12.3.4 Expansions
12.3.5 Other Developments
12.4 Vendor Inclusion Criteria
12.5 Competitive Leadership Mapping
12.5.1 Visionary Leaders
12.5.2 Innovators
12.5.3 Dynamic Differentiators
12.5.4 Emerging Players

13 Company Profile
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, FutureWise Key Takeaways View)*
13.1 Agilent Technologies, Inc.
13.2 Becton, Dickinson and Company
13.3 Beckman Coulter (A Subsidiary of Danaher)
13.4 F. Hoffmann-La Roche AG
13.5 Illumina, Inc.
13.6 New England Biolabs, Inc.
13.7 Nugen Technologies, Inc. (Part of Tecan Trading Ag)
13.8 Oxford Gene Technology (Part of Sysmex)
13.9 Oxford Nanopore Technologies, Ltd.
13.10 Pacific Biosciences of California, Inc.
13.11 Perkinelmer, Inc.
13.12 QIAGEN N.V.
13.13 Raindance Technologies, Inc. (Part of Bio-Rad Laboratories)
13.14 Swift Biosciences Inc.
13.15 Thermo Fisher Scientific Inc.

14. Research Finding and Conclusion
15. Appendix
15.1 Research Methodology
15.2 Research Data Source

Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com